Salvadori Daniel Gesua Sive 4
4 · ABBOTT LABORATORIES · Filed Feb 23, 2024
Insider Transaction Report
Form 4
Salvadori Daniel Gesua Sive
EVP AND GROUP PRESIDENT
Transactions
- Award
Common shares without par value
2024-02-21+15,673→ 135,534 total - Award
Option (right to buy)
2024-02-21+58,898→ 58,898 totalExercise: $116.98From: 2025-02-21Exp: 2034-02-20→ Common Shares (58,898 underlying)
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,632 on February 21, 2025, 19,633 on February 21, 2026, and 19,633 on February 21, 2027.